Cynthia Lynn Anderson serves as Executive at Vistagen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cynthia Lynn Anderson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2025 involved receiving (via award) 6,617 shares valued at $11.2K.
Cynthia Lynn Anderson currently holds 12,801 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cynthia Lynn Anderson has been a net neutral trader of VTGN stock. They have purchased $0 and sold $0 worth of shares.
Cynthia Lynn Anderson's most recent insider trade was on Jun 30, 2025, when they sold 6,617 shares at $1.70 per share.
Get notified when new Form 4 filings are submitted
| $2.96 |
| Discretionary |